Optiray (Ioversol)

Ioversol, the active ingredient in Optiray, is an iodinated contrast media presented as an injection solution for intravenous use. It is used to enhance radiographic imaging in patients undergoing diagnostic procedures such as CT scans and angiography.

GNH USA supplies Optiray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Optiray (ioversol) is an iodinated contrast agent used in radiographic imaging procedures to improve visualization of vascular and tissue structures.

- Contrast‑enhanced CT: provides high‑contrast images of abdominal, thoracic, and cerebral structures. - Angiography: enhances visualization of blood vessels during catheter‑based studies. - Urography: improves delineation of the urinary tract. - Arthrography: clarifies joint spaces for musculoskeletal imaging. - Myelography: highlights the spinal canal and nerve roots. - Cardiac catheterization: aids in coronary artery imaging.

Adverse reactions to Optiray may range from mild to severe and should be monitored during and after administration.

Common Side Effects: - Warmth or flushing sensation. - Metallic taste in the mouth. - Nausea or mild vomiting. - Headache or mild dizziness. - Transient urticaria or skin itching. - Mild hypotension.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Acute renal toxicity or worsening of pre‑existing kidney disease. - Severe hypotension or cardiovascular collapse. - Pulmonary edema or respiratory distress. - Cardiac arrhythmias. - Seizures or neurological events.

Prior to using Optiray, clinicians should assess patient risk factors and follow safe handling practices.

- Renal function assessment: evaluate serum creatinine and eGFR before administration. - Allergy screening: confirm no prior iodine or contrast media hypersensitivity. - Hydration: ensure adequate patient hydration to reduce renal stress. - Dose minimization: use the lowest effective volume for the specific imaging study. - Thyroid monitoring: avoid in patients with uncontrolled hyperthyroidism due to iodine load. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ioversol may interact with other agents that affect renal function or iodine metabolism.

Major Interactions (Avoid): - Concurrent iodinated contrast agents: cumulative iodine load can increase toxicity. - Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs, high‑dose IV contrast): heighten risk of renal impairment. - Uncontrolled hyperthyroidism: excess iodine may precipitate thyroid storm. - Metformin in patients with reduced renal function: risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate volume depletion and renal stress. - ACE inhibitors or ARBs: monitor renal function and blood pressure. - Anticoagulants: observe for bleeding complications during invasive imaging. - Steroids: may influence fluid balance and renal handling.